NCT05479474 is a NA clinical trial of Platelet rich plasma in Male Infertility, sponsored by Stanford University.

Who is sponsoring NCT05479474?

NCT05479474 is sponsored by Stanford University.

What drugs are being tested in NCT05479474?

Interventions in NCT05479474: Platelet rich plasma.

What condition does NCT05479474 study?

NCT05479474 studies Male Infertility, Nonobstructive Azoospermia, Azoospermia.

Is NCT05479474 still recruiting?

NCT05479474 is currently recruiting now. Last updated 13 January 2026.

Last reviewed 2026-01-13 · How we verify

NCT05479474

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Platelet Rich Plasma Testis Treatment for Infertile Men

Recruiting now NA Last updated 13 January 2026

What this trial tests

NA trial testing Platelet rich plasma in Male Infertility in 10 participants. Currently enrolling.

Timeline

18 January 2023

Primary endpoint
31 December 2026

31 December 2026

Quick facts

Lead sponsor	Stanford University
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	10
Start date	18 January 2023
Primary completion	31 December 2026
Estimated completion	31 December 2026
Sites	1 location across United States

Drugs / interventions tested

Platelet rich plasma — full drug profile →

Conditions studied

Male Infertility — all drugs for Male Infertility →
Nonobstructive Azoospermia — all drugs for Nonobstructive Azoospermia →
Azoospermia — all drugs for Azoospermia →

Sponsor

Stanford University

Who can join

18 and older, male only, with Male Infertility or Nonobstructive Azoospermia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Investigate the effect of intratesticular injection of autologous platelet rich plasma (PRP) on sperm retrieval rates and IVF outcomes in infertile men who already underwent a negative sperm retrieval. Currently, there is no alternative treatment after failed TESE. Prior series suggest that intratesticular PRP injections may improve TESE outcomes. We hope to determine whether PRP is an effective treatment for this patient population.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Platelet-Rich Plasma in Sperm Processing for Assisted Reproductive Technology: Molecular Mechanisms, Clinical Applications, and Future Directions
Petrović D, Dinić M, Švraka D, Pantović V, et al · · 2026

Verify or expand the search:

Other trials of Platelet rich plasma

Trials testing the same drug.

NCT06510673 — Extracorporeal Shock Wave Therapy Versus High Power LASER Therapy for the Treatment of Females With Calcaneal Spur · NA · not yet recruiting
NCT06532318 — Comparative Study Between Platelet Rich Plasma and Steroid Injection in Trigger Finger Treatment · Phase 3 · not yet recruiting
NCT06814535 — A Comparative Study on the Impact of Trigger Points Injection of Platelet Rich Plasma Versus Botulinum Toxin on the Reli · Phase 2, PHASE3 · active not recruiting
NCT06440655 — The Efficacy and Safety of Platelet-rich Fibrin and Platelet Rich Plasma in Female Pattern Hair Loss Patients · NA · recruiting
NCT05666492 — "Platelet Rich Plasma for the Management of Post-Viral Olfactory Dysfunction. · NA · unknown

Other recruiting trials for Male Infertility

Currently open trials in the same condition.

NCT07375238 — Effect of Daily Intake of Gazpacho on Semen Quality and Oxidative Stress · NA · recruiting
NCT07369362 — To Investigate if the Harvester® Improves Sperm Motility and Blastocyst Utilization (the Percent of Fertilized Eggs That · NA · active not recruiting
NCT06956287 — The Efficiency of a New Sperm-Wash Device for Intrauterine Insemination in Couples With Infertility · NA · recruiting
NCT06561451 — Live Birth Rate Between ICSI and AOA and ICSI Alone in Patients With Severe Teratospermia · NA · recruiting
NCT07056400 — Trial to Improve Fertilization Rate and Embryo Development in Intracytoplasmic Sperm Injection (ICSI) Cycles · NA · active not recruiting

Other Stanford University trials

Trials by the same sponsor.

NCT05945147 — Ketamine and Midazolam Infusions for CRPS: Feasibility Study · Phase 2 · withdrawn
NCT04225949 — Patients Understanding of PROM Graphs · NA · withdrawn
NCT06273098 — School-Based Bladder Health Intervention · NA · withdrawn
NCT04652635 — Management of Nailbed Injuries · NA · withdrawn
NCT05443503 — Stanford Spine Keeper - Managing Your Low Back Pain · NA · suspended

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05479474 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Stanford University
Last refreshed: 13 January 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05479474.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing